1. Nobiletin as a chemopreventive natural product against cancer, a comprehensive review
   Yun-Yi Chen et al, 2023, Critical Reviews in Food Science and Nutrition CrossRef
2. Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview
   Eunus S. Ali et al, 2022, Cancer Cell International CrossRef
3. The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention
   Ranjini Sankaranarayanan et al, 2019, Cancers CrossRef
4. PRDX2 removal inhibits the cell cycle and autophagy in colorectal cancer cells
   Xiangru Zheng et al, 2020, Aging CrossRef
5. Exploring the potential of chromone scaffold compounds in cancer therapy: targeting key kinase pathways
   Rajibul Islam et al, 2023, Medicinal Chemistry Research CrossRef
6. Recent developments in mitogen activated protein kinase inhibitors as potential anticancer agents
   Vikram Jeet Singh et al, 2021, Bioorganic Chemistry CrossRef
7. Recent Research on Flavonoids and their Biomedical Applications
   Kangmei Wen et al, 2021, Current Medicinal Chemistry CrossRef
8. Nobiletin as a Molecule for Formulation Development: An Overview of Advanced Formulation and Nanotechnology-Based Strategies of Nobiletin
   Siddharth S. Kesharwani et al, 2020, AAPS PharmSciTech CrossRef
9. Mathematical modeling method of cell tension and compression based on multi-modal mechanical signals
   Dongyang Pan et al, 2021, Journal of Intelligent & Fuzzy Systems CrossRef
10. Anti-HBV therapeutic potential of small molecule 3,5,6,7,3′,4′-Hexamethoxyflavone in vitro and in vivo
    Ming Tan et al, 2021, Virology CrossRef
11. The Application of Citrus folium in Breast Cancer and the Mechanism of Its Main Component Nobiletin: A Systematic Review
    Yuan Wu et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
12. The Orange Peel: An Outstanding Source of Chemical Resources
    Gianfranco Fontana, 2021, Citrus - Research, Development and Biotechnology CrossRef
13. Flavone-based arylamides as potential anticancers: Design, synthesis and in vitro cell-based/cell-free evaluations
    Ahmed H.E. Hassan et al, 2020, European Journal of Medicinal Chemistry CrossRef
14. Docking-based strategy to design novel flavone-based arylamides as potent V600E-BRAF inhibitors with prediction of their drug-likeness and ADMET properties
    Abdullahi Bello Umar et al, 2020, Bulletin of the National Research Centre CrossRef
15. A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
    null Braicu et al, 2019, Cancers CrossRef
16. Nobiletin inhibits breast cancer cell migration and invasion by suppressing the IL-6-induced ERK-STAT and JNK-c-JUN pathways
    Yuan Wu et al, 2023, Phytomedicine CrossRef
17. Polymethoxylated flavonoids in citrus fruits: absorption, metabolism, and anticancer mechanisms against breast cancer
    Yiyu Wang et al, 2024, PeerJ CrossRef
18. New flavone-based arylamides as potential V600E-BRAF inhibitors: Molecular docking, DFT, and pharmacokinetic properties
    Abdullahi B. Umar et al, 2023, Journal of Taibah University Medical Sciences CrossRef
19. Nobiletin bioactivation in MDA-MB-468 breast cancer cells by cytochrome P450 CYP1 enzymes
    Somchaiya Surichan et al, 2018, Food and Chemical Toxicology CrossRef